The molecular basis of targeting protein kinases in cancer therapeutics.

Abstract excerpt

In this paper, we provide an overview of targeted anticancer therapies with small molecule kinase inhibitors. First, we discuss why a single constitutively active kinase emanating from a variety of aberrant genetic alterations is capable of transforming a normal cell, leading it to acquire the hallmarks of a cancer cell. To draw attention to the fact that kinase inhibition in targeted cancer therapeutics differs...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Enzyme Activation
• Share to ErbB Receptors
• Share to Models, Molecular